COVID-19: Mystery Company Eyes EU Approval For Dexamethasone Taw

 
• By Neena Brizmohun

The European Medicines Agency has started reviewing under its fast-track pathway an application to market Dexamethasone Taw as a treatment for hospitalized patients with COVID-19.

multiexposure background coronavirus COVID 19 infected blood sample in sample tube in hand of scientist in coronavirus research laboratory with DNA strain, coronavirus covid 19 vaccine research
Dexamethasone has shown promise as a treatment for hospitalized patients with COVID-19 • Source: Shutterstock

More from Product Reviews

More from Pink Sheet